Home
BCTXW
BCTXW News

Latest BriaCell Therapeutics Corp. Warrant (BCTXW) News on December 18, 2024

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

21 hours ago

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

21 hours ago

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

MT Newswires

5 days ago

BriaCell Therapeutics Raises $5.55 Million in an Underwritten Offering of Share Units

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

GlobeNewswire

5 days ago

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire

5 days ago

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire

7 days ago

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

MT Newswires

7 days ago

BriaCell Therapeutics Plans Public Offering; Shares Plunge After Hours

BriaCell Therapeutics Announces Proposed Public Offering

GlobeNewswire

7 days ago

BriaCell Therapeutics Announces Proposed Public Offering

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

GlobeNewswire

7 days ago

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

16 days ago

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire

22 days ago

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

BriaCell Provides Update to its Board of Directors

GlobeNewswire

23 days ago

BriaCell Provides Update to its Board of Directors

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

GlobeNewswire

a month ago

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire

a month ago

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

GlobeNewswire

a month ago

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

MT Newswires

2 months ago

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

GlobeNewswire

2 months ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

MT Newswires

2 months ago

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

GlobeNewswire

2 months ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

MT Newswires

3 months ago

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

MT Newswires

3 months ago

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires

3 months ago

BriaCell Therapeutics Down 41% as it Announces US$5-Million Share-Unit Offering

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces $5 Million Offering

MT Newswires

3 months ago

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire

3 months ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks

3 months ago

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

MT Newswires

3 months ago

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

GlobeNewswire

3 months ago

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

MT Newswires

3 months ago

BriaCell Therapeutics Closes $8.5 Million Offering

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

MT Newswires

3 months ago

BriaCell Therapeutics Announces US$8.5 Million Share Offering

MT Newswires

3 months ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires

3 months ago

BriaCell Therapeutics Prices $8.5 Million Offering

BriaCell Therapeutics Announces $8.5 Million Offering

GlobeNewswire

3 months ago

BriaCell Therapeutics Announces $8.5 Million Offering

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

Benzinga

3 months ago

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

MT Newswires

3 months ago

Update: BriaCell Shares Surge After Reporting Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study

MT Newswires

3 months ago

Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday

MT Newswires

3 months ago

BriaCell Reports Longer Overall Survival Rate in Phase 2 Breast Cancer Study

MT Newswires

3 months ago

BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

GlobeNewswire

3 months ago

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer

MT Newswires

3 months ago

BriaCell Receives Positive Feedback From FDA Meeting Over Potential Prostate Cancer Drug

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

GlobeNewswire

3 months ago

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate Cancer

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire

3 months ago

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

5 months ago

BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer

BriaCell Presents Clinical Efficacy Data at ASCO 2024

GlobeNewswire

6 months ago

BriaCell Presents Clinical Efficacy Data at ASCO 2024

MT Newswires

7 months ago

BriaCell Begins Patient Enrollment in First-in-Human Study of Bria-OTS in Advanced Metastatic Breast Cancer

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

GlobeNewswire

7 months ago

BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer

MT Newswires

7 months ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study

MT Newswires

7 months ago

BriaCell Therapeutics, BeiGene Partner to Test Combination of Companies' Cancer Treatments

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study

GlobeNewswire

7 months ago

BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

GlobeNewswire

7 months ago

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

Simply Wall St.

7 months ago

This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year

MT Newswires

7 months ago

Briacell Therapeutics Insider Bought Shares Worth $2,000,001, According to a Recent SEC Filing

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

MT Newswires

7 months ago

BriaCell Therapeutics Prices $5 Million Offering; Shares Tumble

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering

MT Newswires

8 months ago

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting

BriaCell Announces Oral and Poster Presentations at ASCO 2024

GlobeNewswire

8 months ago

BriaCell Announces Oral and Poster Presentations at ASCO 2024

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

GlobeNewswire

8 months ago

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

GlobeNewswire

8 months ago

BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

GlobeNewswire

9 months ago

BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

GlobeNewswire

9 months ago

BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

GlobeNewswire

10 months ago

BriaCell Provides Update on Alleged Illegal Trading of Public Securities

Get Rich Quick With These 3 Penny Stocks to Buy Now

InvestorPlace

10 months ago

Get Rich Quick With These 3 Penny Stocks to Buy Now

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

GlobeNewswire

10 months ago

BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

GlobeNewswire

10 months ago

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire

a year ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Merchants Bancorp (MBIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a year ago

Merchants Bancorp (MBIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Reuters

a year ago

UPDATE 1-Brazil's Lula slams miner Vale over 2019 Brumadinho disaster

GlobeNewswire

a year ago

Optical Brighteners Market to Hit US$ 2,656.2 Million by 2033 | Updated Insights Report by Persistence Market Research

GlobeNewswire

a year ago

Irradiation Sterilization Services Market anticipated to grow at CAGR of 9.2% by 2030, According to Persistence Market Research

Q-Gold Comments on Trading Activity at Request of the Canadian Investment Regulatory Organization (“CIRO”)

GlobeNewswire

a year ago

Q-Gold Comments on Trading Activity at Request of the Canadian Investment Regulatory Organization (“CIRO”)

Manufacturing Activity in Central U.S. Drops Sharply at Start of Year

Barrons.com

a year ago

Manufacturing Activity in Central U.S. Drops Sharply at Start of Year

GlobeNewswire

a year ago

Automatic Self-cleaning Cat Litter Box Market to Hit US$ 1,262.7 Million by 2030 | Updated Insights Report by Persistence Market Research

Global Automated Parking System (APS) Market Set to Reach $6.6 Billion by 2030: Surging Demand for Space-Efficient and Technologically Advanced Vehicle Storage Solutions

GlobeNewswire

a year ago

Global Automated Parking System (APS) Market Set to Reach $6.6 Billion by 2030: Surging Demand for Space-Efficient and Technologically Advanced Vehicle Storage Solutions

Data Storage Corporation Expands Contract with a Global Telecommunications Company

GlobeNewswire

a year ago

Data Storage Corporation Expands Contract with a Global Telecommunications Company

Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company

GlobeNewswire

a year ago

Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company

Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR

ACCESSWIRE

a year ago

Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR

Atlantic Union (AUB) Beats Q4 Earnings and Revenue Estimates

Zacks

a year ago

Atlantic Union (AUB) Beats Q4 Earnings and Revenue Estimates

Silynxcom Announces Closing of Initial Public Offering

GlobeNewswire

a year ago

Silynxcom Announces Closing of Initial Public Offering

Akerna Announces Special Meeting Date to Vote on Merger with Gryphon Digital Mining, Inc.; Effectiveness of Registration Statement on Form S-4 in Connection with Merger

GlobeNewswire

a year ago

Akerna Announces Special Meeting Date to Vote on Merger with Gryphon Digital Mining, Inc.; Effectiveness of Registration Statement on Form S-4 in Connection with Merger

ACCESSWIRE

a year ago

Nocera Inc. Announces Senior Leadership Change

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million

Business Wire

a year ago

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million

Business Wire

a year ago

Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

Business Wire

a year ago

Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

GlobeNewswire

a year ago

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

ACCESSWIRE

a year ago

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

$BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset$

GlobeNewswire

a year ago

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset

Zacks Small Cap Research

a year ago

BCTX: Down in San Antone

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

GlobeNewswire

a year ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Why Fast-paced Mover Cemtrex Inc. (CETX) Is a Great Choice for Value Investors

Zacks

a year ago

Why Fast-paced Mover Cemtrex Inc. (CETX) Is a Great Choice for Value Investors

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS

GlobeNewswire

a year ago

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS

BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit

GlobeNewswire

a year ago

BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit

Did Motus Holdings Limited (JSE:MTH) Use Debt To Deliver Its ROE Of 19%?

Simply Wall St.

a year ago

Did Motus Holdings Limited (JSE:MTH) Use Debt To Deliver Its ROE Of 19%?

Sunshine Biopharma Moves Principal Office to New York City

GlobeNewswire

a year ago

Sunshine Biopharma Moves Principal Office to New York City

STRATA Skin Science Announces Strengthening of Leadership Team

GlobeNewswire

a year ago

STRATA Skin Science Announces Strengthening of Leadership Team

Reborn Coffee Announces Grand Opening of Flagship Store in Kuala Lumpur, Malaysia

GlobeNewswire

a year ago

Reborn Coffee Announces Grand Opening of Flagship Store in Kuala Lumpur, Malaysia

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

GlobeNewswire

a year ago

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

Share on Social Networks: